Diabetes business on fast track after FDA approval of MiniMed 780G system, warning letter resolution
In this episode of MedtronicTalks, Que Dallara, EVP and President of the Diabetes Business at Medtronic, discusses the company’s recent advancements in diabetes management.
Dallara, transitioning from the software and technology industry to the medical device industry, draws parallels between control systems in different fields and their application to diabetes management, particularly in the development of closed-loop algorithms for insulin dosing. She also highlights the FDA-approved MiniMed 780G system, which simplifies diabetes management with automatic adjustments for insulin dosing and carbohydrate counting. Finally, Dallara addresses Medtronic’s ongoing engagement with the FDA and news of the launch of the MiniMed 780G system in the U.S., sharing more about its meal detection technology and benefits.
Thank you to GlobalMed-MDI for sponsoring this episode. To learn more about how GlobalMed-MDI works with medical device companies, visit www.moldeddevices.com.
Thank you for listening to the Medtronic Podcast.
Subscribe to this podcast on every major podcast platform.